Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence
Study Information
Alliance Study ID: CALGB-99801
NCT Study ID (ClinicalTrials.gov): NCT00003858
Alliance Committee: Genitourinary Cancer
Disease or Cancer Type: Prostate Cancer
Alliance Study Chair: Joseph C. Presti, MD
Status: WITHDRAWN
Study Description
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving chemotherapy after surgery may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of mitoxantrone given after surgery in treating patients who have prostate cancer that is at high risk for recurrence.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information